CHM chimeric therapeutics limited

Ann: Phase 1B CHM CORE-NK trial advances to newly diagnosed AML, page-15

  1. 4,416 Posts.
    lightbulb Created with Sketch. 4569
    Another response or two in liquid tumours and they'll be able to flip CHM for a couple multiples of .08c.

    Venetoclax only on the market for a few years now and is rapidly gaining market share. Any synergy here would surely result in more than a 'couple' of multiples.

    Biggest risk still the possibility of another massively dilutionary raise.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.